台股 » 太醫 » 個股財報 » 每股盈餘成長率(季增率)
- 股價
89.3
- 漲跌
▲0.4
- 漲幅
+0.45%
- 成交量
21張
- 產業
上櫃 生技醫療類股
▲0.20%
-
本地時間:13:30(已收盤)
太醫 (4126) 財務報表－每股盈餘成長率(季增率)
EPS成長率
EPS季增率 = (單季EPS÷上季EPS)-1。
EPS年增率 = (單季EPS÷去年同季EPS)-1。
太醫 (4126) 歷年EPS季增率
| 年度/季別 | EPS季增率 | 近4季EPS季增率 | 年度/季別 | EPS季增率 | 近4季EPS季增率 |
|---|
| 2024Q3 | 31.88% | 1.97% | 2021Q3 | 277.33% | 40.43% |
| 2024Q2 | -6.76% | -2.45% | 2021Q2 | -36.44% | -12.92% |
| 2024Q1 | 46.53% | -1.38% | 2021Q1 | 6.31% | 5.96% |
| 2023Q4 | -40.94% | -6.6% | 2020Q4 | -2.63% | -28.1% |
| 2023Q3 | 12.5% | 2.48% | 2020Q3 | -16.79% | -0.16% |
| 2023Q2 | -2.56% | 13.27% | 2020Q2 | 50.55% | -0.16% |
| 2023Q1 | 9.86% | 17.32% | 2020Q1 | -68.4% | 0% |
| 2022Q4 | -8.97% | 23.24% | 2019Q4 | 150.43% | 40.13% |
| 2022Q3 | 92.59% | -25.55% | 2019Q3 | -16.67% | 2.97% |
| 2022Q2 | 5.19% | 1.22% | 2019Q2 | 51.65% | 20.66% |
| 2022Q1 | 37.5% | -7.71% | 2019Q1 | -14.95% | 10.67% |
| 2021Q4 | -80.21% | -9.37% | | | |
太醫前9月稅前盈餘4.34億元 年增逾5成Anue鉅亨－2023/10/13
太醫攜仁德醫專、弘光科大 培養智醫人才Anue鉅亨－2023/06/20
複製保瑞模式！生技股鐿鈦、聯合、太醫接棒！Anue鉅亨－2023/04/25